Does the length of uvula affect the palatal implant outcome in the management of habitual snoring?


Akpinar M. E., YİĞİT Ö., Kocak I., Altundag A.

Laryngoscope, cilt.121, sa.5, ss.1112-1116, 2011 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 121 Sayı: 5
  • Basım Tarihi: 2011
  • Doi Numarası: 10.1002/lary.21731
  • Dergi Adı: Laryngoscope
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1112-1116
  • Anahtar Kelimeler: Snoring, palatal implants, uvula, length
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Objectives/Hypothesis: To evaluate the impact of the uvular length on the efficacy of palatal implants in primary snoring. Study Design: Prospective case series, tertiary hospital, snoring and respiratory sleep disorders center. Methods: Forty subjects with inserted palatal implants and diagnoses of primary snoring were included. All met the inclusion criteria of age >18 years, body mass index <30, apnea-hypopnea index <5, tonsil grade <3, soft-palate length >25 mm, and Friedman tongue position <3 following clinical, endoscopic, and polysomnographic evaluation. Epworth sleepiness scale (ESS) and the snoring-intensity visual analogue scale (VAS) were recorded before and 9 months after the implant. Four subjects with extruded implants were excluded; the remaining 36 subjects were divided into two groups, Group I and Group II, with uvular lengths of ≤15 mm and >amp;15 mm, respectively. The study assessed and compared subjective outcome measures including the partner's satisfaction (PS), partner's reported improvement (PRI), 50% VAS and ESS reduction, and subjective success (SS) defined as 50% VAS reduction. The Student t test, I;umlbsupesup& test, and logistic regression models were used for statistical evaluation. Results: SS (50% VAS reduction), PS, PRI, and 50% ESS reduction were significantly higher in Group I (P <.001, P =.0257, P =.027, P <.001). The overall SS, PRI, PS, and 50% ESS reduction were 33%, 78%, 50%, and 50%, respectively. The uvular length was found to be the determinant factor of SS (P =.005; odds ratio = 0.75), PRI (P =.039; odds ratio = 0.83), and 50% ESS reduction (P =.038; odds ratio: 0.84) following implant insertion through stepwise logistic regression analysis. Conclusions: Excess uvular length (>15 mm) is an important anatomic feature decreasing the efficacy of palatal implants in snoring, and additional measures, such as uvulectomy, should be considered simultaneously for better outcomes (level 4). © 2011 The American Laryngological, Rhinological, and Otological Society, Inc.